ABEO insider buying and SEC filings, explained
Abeona Therapeutics Inc. · CIK 318306
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$2.9M
Planned sales (10b5-1)
$674K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 29, 2026 | Sale | Vishwas Seshadri (CEO and Director) sold 19,608 shares at about $5.16 ($101K). Holdings down 2% to 1,286,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 29, 2026 |
| Sep 29, 2026 | Sale | Joseph Walter Vazzano (CFO) sold 9,191 shares at about $5.16 ($47K). Holdings down 2% to 482,888 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 29, 2026 |
| Sep 29, 2026 | Sale | Brendan M. O'Malley (SVP, Chief Legal Officer) sold 6,727 shares at about $5.16 ($35K). Holdings down 2% to 421,226 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 29, 2026 |
| Sep 29, 2026 | Sale | Madhav Vasanthavada (Chief Commercial Officer) sold 4,902 shares at about $5.16 ($25K). Holdings down 2% to 285,721 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 29, 2026 |
| Sep 1, 2026 | Sale | Mark Alvino (Director) sold 15,000 shares at about $5.86 ($88K). Holdings down 19% to 62,065 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 1, 2026 |
| Jul 21, 2026 | Sale | Joseph Walter Vazzano (CFO) sold 1,478 shares at $6.53 ($10K). Holdings down <1% to 492,079 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 22, 2026 |
| Jul 9, 2026 | Sale | Joseph Walter Vazzano (CFO) sold 24,880 shares at about $6.96 ($173K). Holdings down 5% to 493,557 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 9, 2026 |
| Jul 9, 2026 | Sale | Vishwas Seshadri (CEO and Director) sold 67,971 shares at about $6.96 ($473K). Holdings down 5% to 1,306,108 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 9, 2026 |
| Jul 9, 2026 | Sale | Brendan M. O'Malley (SVP, Chief Legal Officer) sold 12,050 shares at about $6.96 ($84K). Holdings down 3% to 427,953 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 9, 2026 |
| Jul 9, 2026 | Sale | Madhav Vasanthavada (Chief Commercial Officer) sold 12,606 shares at about $6.96 ($88K). Holdings down 4% to 290,623 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 9, 2026 |
| Jun 30, 2026 | Sale | Leila Alland (Director) sold 11,000 shares at about $5.92 ($65K). Holdings down 6% to 162,614 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 2, 2026 |
| Jun 15, 2026 | Sale | Christine Berni Silverstein (Director) sold 18,160 shares at about $5.71 ($104K). Holdings down 13% to 119,562 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 8–9, 2026 | Planned (10b5-1) | Joseph Walter Vazzano (CFO) sold 49,338 shares between Jun 8 and Jun 9 at about $5.37 ($265K), marked as a 10b5-1 plan trade. Holdings down 9% to 518,437 shares. | SEC filing Filed Jun 9, 2026 |
| Jun 8–9, 2026 | Sale | Madhav Vasanthavada (Chief Commercial Officer) sold 9,620 shares between Jun 8 and Jun 9 at about $5.36 ($52K). Holdings down 3% to 303,451 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| Jun 8–9, 2026 | Sale | Vishwas Seshadri (CEO and Director) sold 56,344 shares between Jun 8 and Jun 9 at about $5.36 ($302K). Holdings down 4% to 1,374,079 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| Jun 8–9, 2026 | Sale | Brendan M. O'Malley (SVP, Chief Legal Officer) sold 11,131 shares between Jun 8 and Jun 9 at about $5.36 ($60K). Holdings down 2% to 440,003 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| May 22, 2026 | Sale | Mark Alvino (Director) sold 6,500 shares at about $5.46 ($35K). Holdings down 8% to 77,565 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 15, 2026 | Planned (10b5-1) | Eric Crombez (Director) sold 26,143 shares at about $5.53 ($145K), marked as a 10b5-1 plan trade. Holdings down 41% to 37,313 shares. | SEC filing Filed May 15, 2026 |
| May 11, 2026 | Sale | Madhav Vasanthavada (Chief Commercial Officer) sold 5,548 shares at about $5.96 ($33K). Holdings down 2% to 313,071 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| Mar 31, 2026 | Planned (10b5-1) | Vishwas Seshadri (CEO and Director) sold 29,985 shares at about $4.38 ($131K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,430,423 shares. | SEC filing Filed Mar 31, 2026 |
| Mar 16, 2026 | Sale | Joseph Walter Vazzano (CFO) sold 785 shares at $4.76 ($4K). Holdings down <1% to 567,775 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Feb 2, 2026 | Sale | Christine Berni Silverstein (Director) sold 20,070 shares at about $5.09 ($102K). Holdings down 13% to 137,722 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Feb 2, 2026 | Sale | Donald A. Wuchterl (Director) sold 14,814 shares at about $5.09 ($75K). Holdings down 8% to 167,935 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 2, 2026 |
| Feb 2, 2026 | Sale | Eric Crombez (Director) sold 16,284 shares at about $5.09 ($83K). Holdings down 20% to 63,456 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 2, 2026 |
| Feb 2, 2026 | Sale | Leila Alland (Director) sold 18,065 shares at about $5.09 ($92K). Holdings down 9% to 173,614 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 2, 2026 |
| Feb 2, 2026 | Sale | Mark Alvino (Director) sold 2,000 shares at about $5.09 ($10K). Holdings down 2% to 84,065 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 2, 2026 |
| Jan 22, 2026 | Sale | Madhav Vasanthavada (Chief Commercial Officer) sold 12,610 shares at about $5.29 ($67K). Holdings down 4% to 318,619 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 26, 2026 |
| Jan 22, 2026 | Sale | Joseph Walter Vazzano (CFO) sold 18,666 shares at about $5.33 ($99K). Holdings down 3% to 568,560 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 22, 2026 |
| Jan 22, 2026 | Sale | Vishwas Seshadri (CEO and Director) sold 69,832 shares at about $5.33 ($372K). Holdings down 5% to 1,460,408 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 22, 2026 |
| Jan 22, 2026 | Sale | Brendan M. O'Malley (SVP, Chief Legal Officer) sold 13,578 shares at about $5.33 ($72K). Holdings down 3% to 451,134 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 22, 2026 |
| Jan 21, 2026 | Sale | Mark Alvino (Director) sold 13,500 shares at about $5.23 ($71K). Holdings down 22% to 48,752 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 21, 2026 |
| Dec 29, 2025 | Planned (10b5-1) | Vishwas Seshadri (CEO and Director) sold 25,000 shares at about $5.31 ($133K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,164,818 shares. | SEC filing Filed Dec 29, 2025 |
| Nov 13, 2025 | Sale | Mark Alvino (Director) sold 15,000 shares at about $4.74 ($71K). Holdings down 19% to 62,252 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 14, 2025 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ABEO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.